hotspot -WSS

hotspot

author：Wikipedia 2025-09-02 08:18:38 - browse：7734

A pile of Zynex Medical batteries and electrode pads are seen at Michelle Bean's home — A pile of Zynex Medical batteries and electrode pads Kayana Szymczak for STAT

Sending patients heaps of medical supplies to score more money from insurers is common in the device industry. If insurers decline to cover the supplies, patients are stuck paying for materials they didn’t need.

STAT examined one of the companies perpetuating this practice, a pain management device company called Zynex Medical, and the frustration among both its patients and former employees. Here are five takeaways.

The ‘razor blade’ business model

Zynex sells nerve and muscle stimulation machines, known as TENS and EMS units, to treat pain and soothe muscles. But the company makes most of its money from monthly shipments of batteries and electrodes — almost 70% of its $184 million revenue in 2023 came from these supplies.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： Air quality improving but still lags in Black, Hispanic communities

WSS

Greece's new parliament sworn in following conservative party's election victory

The Readout: Amylyx, Alumis, and Lundbeck drug updates

NEJM study link tiny plastics in blood vessels to heart problems

With psoriasis trial ahead, Alumis raises $259 million

How to bring more disabled researchers into academia

Former medical device CEO who sold dummy, plastic parts convicted of fraud

leisure time

hotspot

The ‘razor blade’ business model

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

leisure time

In Memoriam: Notable people who died in 2023

Headspace, Meta partner to launch VR meditation app for Quest

The high cost of giving birth even with insurance

Legitimacy of 'customer' in Supreme Court gay rights case raises ethical, legal flags

Drug repurposing or repositioning? The language matters

Headspace, Meta partner to launch VR meditation app for Quest

Guidelines to prevent youth baseball injuries need more muscle

The Readout: Amylyx, Alumis, and Lundbeck drug updates

Moonlake's readout produced a cash windfall. Risks remain

Novo Nordisk obesity pill bests Wegovy in early trial

knowledge

IVF, abortion rights issues kick off Biden’s State of the Union

The drug industry has found itself all alone in Washington

Precocious puberty in girls comes with mental health risks

Noem? Reynolds? A very early look at the Republican 'veepstakes'

First medicine developed to treat MASH expected to be approved soon

Headspace, Meta partner to launch VR meditation app for Quest

Wikipedia

knowledge

hotspot

entertainment